drugset / Trial / NCT01800682
A Pharmacokinetic Study to Evaluate the Dose-Proportionality of Tramadol (ULTRAM) Extended-Release (ER) in Healthy Participants
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the dose proportionality of the pharmacokinetics (explores what the body does to the drug) of tramadol in healthy adult participants.
Timeline
- Start
- 2011-07
- Primary completion
- 2011-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tramadol | Other / unclassified | 25 mg | Oral |
| Subject | Tramadol | Other / unclassified | 50 mg | Oral |
| Subject | Tramadol | Other / unclassified | 100 mg | Oral |
Indications
No indication recorded.